Strategic Funding for Secure Data Collaboration
Apheris Secures €20.1 million in a Series A funding round, strengthening its mission to empower secure and collaborative data networks in the life sciences sector. Led by European DeepTech investors OTB Ventures and eCAPITAL, the funding round also saw participation from existing backers Octopus Ventures and Heal Capital.
Apheris CEO Robin Röhm expressed his excitement about the new partnerships, highlighting the investors’ deep understanding of high-security, advanced technology products. “With their support, we aim to unlock the potential of AI and machine learning in the life sciences industry by addressing the critical bottleneck of accessing large and diverse data,” Röhm stated. The startup’s innovative Compute Gateway allows AI models to be trained on sensitive data without moving it, making regulatory and commercial hurdles manageable. Pharmaceutical giants like Roche and Johnson & Johnson, along with hospitals, have already adopted Apheris’ technology.
Unleashing Untapped Potential in Healthcare Data
Apheris secures a significant advantage in the healthcare industry with its federated computing technology, addressing the challenge where 97% of data remains unused due to trust and privacy concerns. By facilitating secure data collaboration while safeguarding intellectual property, Apheris taps into a market valued at over €29 billion.
The fresh funding will enable Apheris to scale its operations, expand its network of biopharmaceutical clients, and deploy foundational AI models. The startup plans to host state-of-the-art models, including protein-complex-prediction systems, leveraging previously inaccessible training data stored in private repositories. These developments aim to drive breakthroughs in AI-driven research and innovation, providing end-to-end functionality for critical life sciences use cases.
Backers Praise Apheris’ Revolutionary Approach
The Series A funding round underscores growing confidence in Apheris’ potential to redefine data-driven healthcare solutions. Marcin Hejka, Co-Founder and General Partner at lead investor OTB Ventures emphasized the transformative impact of Apheris’ technology. “By enabling organizations to unlock the full potential of AI/ML workloads while maintaining data security, Apheris is setting new standards for data-driven innovation,” Hejka noted.
Hannes Schill, Managing Partner at eCAPITAL, highlighted the importance of secure data collaboration, particularly in the sensitive life sciences sector. “Apheris enables organizations to unlock value from IP-sensitive data while maintaining full control. We are proud to support their journey to redefine secure data collaboration in healthcare and beyond,” Schill said.
With plans to establish the largest secure life sciences data network by 2025, Apheris Secures its position as a key player in the evolution of AI and data-driven healthcare solutions. Its cutting-edge federated computing technology and growing industry support signal a promising future for secure, collaborative innovation.
